SCHEMBL6992115

SCHEMBL6992115

O=S1(=O)c2ccccc2C(O)CN1CCCCl

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.36
MAPT P10636 2/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
GRIN1 Q05586 3/20 0.34
GRIN2B Q13224 3/20 0.34
SIGMAR1 Q99720 3/20 0.34
KMT2A Q03164 2/20 0.33
MDM2 Q00987 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
PTGDR2 Q9Y5Y4 2/20 0.32
MEN1 O00255 1/20 0.32
ELANE P08246 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002583 0.80 L3MBTL1 (0.40) TDP1MAPTATML3MBTL1KMT2A
SCHEMBL6995842 0.78 L3MBTL1 (0.39) TDP1MAPTATML3MBTL1CTDSP1
SCHEMBL6997105 0.76 L3MBTL1 (0.44) TDP1MAPTATML3MBTL1KMT2A
SCHEMBL7000061 0.76 HTR1A (0.37) L3MBTL1KMT2AMEN1ELANE
SCHEMBL6992366 0.75 HTR1A (0.52) SIGMAR1
SCHEMBL6995519 0.73 HTR7 (0.37) L3MBTL1KMT2AMEN1
SCHEMBL6995673 0.72 HTR2A (0.58)
SCHEMBL6996892 0.71 TDP1 (0.65) TDP1MAPTATMKMT2AMDM2
SCHEMBL6997115 0.70 PER2 (0.48) TDP1MAPTATML3MBTL1SIGMAR1
Ethylene SCHEMBL8644556 0.69 TDP1 (0.62) TDP1MAPTATMKMT2AMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
EP-0686632-B1 BENZOTHIAZINE DERIVATIVE DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-08-06 EP disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
CN-1281854-A Benzothiazine derivative SUNTORY LTD (JP) 2001-01-31 CN disclosed
CN-1058492-C benzothiazine derivatives SUNTORY LTD (JP) 2000-11-15 CN disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
US-5874429-A ANTIISCHEMIC AGENTS; CEREBROVASCULAR DISORDERS; CIRCULATORY IDSORDERS SUNTORY LIMITED (JP) 1999-02-23 US disclosed
CN-1119859-A benzothiazine derivatives SUNTORY LTD (JP) 1996-04-03 CN disclosed
EP-0686632-A1 BENZOTHIAZINE DERIVATIVE SUNTORY LIMITED (JP) 1995-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 TDP1 3378/4885MAPT 4423/4885ATM 3451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.